Debra LaFrankie, RN

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS3
- SINCE2009

Safety Study of XL184 in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
September 2009 - December 2010
Glioblastoma
Gliosarcoma
Radiation Therapy
Temozolomide
Xl184



